Back to SUSQUEHANNA INTERNATIONAL GROUP, LLP SUSQUEHANNA INTERNATIONAL GROUP, LLP

ORMPORMP
24 quarters

Position history for SUSQUEHANNA INTERNATIONAL GROUP, LLPSUSQUEHANNA INTERNATIONAL GROUP, LLP's holdings in ORAMED PHARMACEUTICALS INC

SUSQUEHANNA INTERNATIONAL GROUP, LLP holds 136,218 shares of ORMP (ORAMED PHARMACEUTICALS INC), worth $463,141 as of 2026-Q1. The position was increased (+424.2% shares). ORMP represents 0.0% of SUSQUEHANNA INTERNATIONAL GROUP, LLP's portfolio.

Current Value

$463,141

Current Shares

136,218

Total Value Change

+$416,141

Total Shares Change

+121,414

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Increased
136,218
+424.2%
$463,1410.0%$3.38
39
2025-Q4
Decreased
25,984
-29.4%
$74,0540.0%$2.62
0
2025-Q3
Decreased
36,825
-24.0%
$97,2180.0%$2.52
0
2025-Q2
Decreased
48,428
-51.7%
$108,9630.0%$2.00
0
2025-Q1
Increased
100,196
+10.1%
$214,4190.0%$2.06
17
2024-Q4
Decreased
91,027
-32.3%
$220,2850.0%$2.17
0
2024-Q3
Increased
134,373
+6.8%
$327,8710.0%$2.31
25
2024-Q2
Decreased
125,828
-63.5%
$323,3780.0%$2.40
0
2024-Q1
Increased
344,438
+650.1%
$1M0.0%$2.72
40
2023-Q4
Increased
45,916
+251.4%
$106,0660.0%$2.15
24
2023-Q3
Decreased
13,068
-85.1%
$34,1070.0%$2.43
0
2023-Q2
Increased
87,503
+516.7%
$313,2610.0%$3.33
38
2023-Q1
Decreased
14,189
-92.4%
$30,9320.0%$2.01
0
2022-Q4
Increased
185,606
+8.3%
$2.2M0.0%$11.21
28
2022-Q3
Increased
171,337
+60.7%
$1.1M0.0%$6.05
36
2022-Q2
Increased
106,638
+36.7%
$488,0000.0%$4.20
31
2022-Q1
Decreased
77,985
-33.0%
$675,0000.0%$8.41
0
2021-Q4
Increased
116,408
+608.4%
$1.7M0.0%$12.79
41
2021-Q3
Increased
16,432
+36.9%
$361,0000.0%$20.83
21
2021-Q2
Decreased
12,002
-82.4%
$161,0000.0%$12.47
0
2021-Q1
New
68,305
-
$694,0000.0%$9.43
34
2020-Q1
Exited
0
-100.0%
$00.0%$2.78
0
2019-Q4
Decreased
13,628
-7.9%
$70,0000.0%$4.62
0
2019-Q3
New
14,804
-
$47,0000.0%$2.89
31

Other major holders of ORMP: Invesco Ltd., MILLENNIUM MANAGEMENT LLC, CITADEL ADVISORS LLC, MERCER GLOBAL ADVISORS INC /ADV

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used